348 related articles for article (PubMed ID: 19369348)
21. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
[TBL] [Abstract][Full Text] [Related]
22. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
24. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.
Zhang Y; Chirmule N; Gao Gp; Wilson J
J Virol; 2000 Sep; 74(17):8003-10. PubMed ID: 10933709
[TBL] [Abstract][Full Text] [Related]
25. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.
Scallan CD; Jiang H; Liu T; Patarroyo-White S; Sommer JM; Zhou S; Couto LB; Pierce GF
Blood; 2006 Mar; 107(5):1810-7. PubMed ID: 16249376
[TBL] [Abstract][Full Text] [Related]
26. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.
Giles AR; Govindasamy L; Somanathan S; Wilson JM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698
[TBL] [Abstract][Full Text] [Related]
27. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
Xin KQ; Mizukami H; Urabe M; Toda Y; Shinoda K; Yoshida A; Oomura K; Kojima Y; Ichino M; Klinman D; Ozawa K; Okuda K
J Virol; 2006 Dec; 80(24):11899-910. PubMed ID: 17005662
[TBL] [Abstract][Full Text] [Related]
28. BALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver.
Breous E; Somanathan S; Wilson JM
Mol Ther; 2010 Apr; 18(4):766-74. PubMed ID: 20068550
[TBL] [Abstract][Full Text] [Related]
29. Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopes.
Mays LE; Wilson JM
J Gene Med; 2009 Dec; 11(12):1095-102. PubMed ID: 19777488
[TBL] [Abstract][Full Text] [Related]
30. Complement is an essential component of the immune response to adeno-associated virus vectors.
Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
[TBL] [Abstract][Full Text] [Related]
31. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
[TBL] [Abstract][Full Text] [Related]
32. Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes.
Hui DJ; Basner-Tschakarjan E; Chen Y; Davidson RJ; Buchlis G; Yazicioglu M; Pien GC; Finn JD; Haurigot V; Tai A; Scott DW; Cousens LP; Zhou S; De Groot AS; Mingozzi F
Mol Ther; 2013 Sep; 21(9):1727-37. PubMed ID: 23857231
[TBL] [Abstract][Full Text] [Related]
33. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
Shibagaki N; Udey MC
J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130
[TBL] [Abstract][Full Text] [Related]
35. Liver-Specific Allergen Gene Transfer by Adeno-Associated Virus Suppresses Allergic Airway Inflammation in Mice.
Chan CC; Lai CW; Wu CJ; Chen LC; Tao MH; Kuo ML
Hum Gene Ther; 2016 Aug; 27(8):631-42. PubMed ID: 27178525
[TBL] [Abstract][Full Text] [Related]
36. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone FR; Bevan MJ
J Exp Med; 1989 Mar; 169(3):603-12. PubMed ID: 2784478
[TBL] [Abstract][Full Text] [Related]
37. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
[TBL] [Abstract][Full Text] [Related]
38. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.
Bowles DE; McPhee SW; Li C; Gray SJ; Samulski JJ; Camp AS; Li J; Wang B; Monahan PE; Rabinowitz JE; Grieger JC; Govindasamy L; Agbandje-McKenna M; Xiao X; Samulski RJ
Mol Ther; 2012 Feb; 20(2):443-55. PubMed ID: 22068425
[TBL] [Abstract][Full Text] [Related]
39. Linked foreign T-cell help activates self-reactive CTL and inhibits tumor growth.
Steinaa L; Rasmussen PB; Wegener AM; Sonderbye L; Leach DR; Rygaard J; Mouritsen S; Gautam AM
J Immunol; 2005 Jul; 175(1):329-34. PubMed ID: 15972665
[TBL] [Abstract][Full Text] [Related]
40. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]